Navigation Links
Speedy generic approval may not benefit consumers as much as expected, Rotman model shows
Date:2/8/2011

Toronto Faster approval times for generic drugs will get them into consumers' hands quicker, but may not make the price any better, a pricing and marketing researcher has found.

A mathematical model created by Andrew Ching shows that fewer firms enter the marketplace because the chances of getting there first and commanding the best profits are dramatically smaller when drug approval times are shorter. Ching is an associate professor of marketing at the University of Toronto's Rotman School of Management.

Using the drug clonidine, Prof. Ching's model showed the number of firms in the marketplace dropped by 25 percent, from 12 to nine, under a shortened approval time scenario.

"Potentially, for the consumer, the price may not drop as much as you'd hope," said Prof. Ching.

Under the current situation it takes companies an average of more than 20 months to get U.S. Food and Drug Administration (FDA) approval for generic versions of established drugs. That makes approval times uncertain and companies often must go through several rounds of review. Companies also pay several million dollars when they apply for FDA approval. Given these as well as other development costs, firms making it to the marketplace last sometimes experience losses.

The FDA in recent years has talked about reducing its approval times in order to benefit consumers, and has proposed strategies for how it could do so, including spending more money in order to bring on extra staff to do the reviews.

Prof. Ching says his results, which were published in International Economic Review, suggest the FDA should think twice before going that route.

"Even if the government spends a large amount of resources to improve the efficiency of the FDA in approving generic drugs, it does not necessarily achieve the goal of enhancing welfare," Prof. Ching's paper concludes.


'/>"/>

Contact: Ken McGuffin
mcguffin@rotman.utoronto.ca
416-946-3818
University of Toronto, Rotman School of Management
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Generic drug may improve the effectiveness of cancer nanotherapies
2. Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial
3. SNM applauds FDA advisory committee recommendation for approval of Alzheimers imaging agent
4. FDA Advisers Consider Approval of Genetically Modified Salmon
5. FDA Advisers Weigh Approval of Genetically Modified Salmon
6. FDA Panel Votes Against Approval of Female Viagra
7. Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks
8. US Department of Education Financial Aid Approval
9. Hydroponics Nutrients For Medical Marijuana Gain Government Approval
10. United Nations Approval Rating rises to 60% in New Opinion Poll
11. FDA Warns Cosmetic Doctor about Promoting Anti-Wrinkle Drug before FDA Approval; Unbiased Information on Skin Care a Precious Resource Says SkinTour.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Gordon HealthDay Reporter , , FRIDAY, May 17 (HealthDay ... sometimes binge drink, but new research shows that college women ... a weekly basis than are college men. Much ... that,s considered safe on a weekly basis is much lower ... women versus 14 for men. But, there,s good reason for ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss products ... result of stress, nutrient deficiency or wearing a favorite ... men suffer from male patterned baldness. , ... transplant surgery, but additionally carries a hair care product ... Professional Strength. Their product line is a five-step treatment ...
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic ... Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global ... and studies the major market drivers, restraints, and opportunities ... World. , Browse , 147 ... , 318 pagesand in-depth TOC of ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s ... is all about is getting results in the fastest amount ... ’s Stan Stevenson, prompting an investigative review. , “ ... system” designed to make you faster, stronger, fitter and trimmer ... in the gym. The training manual and exercise video database ...
Breaking Medicine News(10 mins):Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... May 26, 2011Folic acid supplements given to pregnant and ... their offspring by 64 per cent, a new study ... Kim, a gastroenterologist at St. Michael,s Hospital, adds to ... supplementation during pregnancy and lactation can increase or decrease ...
... HealthDay Reporter , THURSDAY, May 26 (HealthDay ... of babes, but their minds are able to form ... new study suggests. Joined by colleagues across the ... has developed a computational model of preverbal infants, "pure ...
... , THURSDAY, May 26 (HealthDay News) -- Caffeine, a ... nausea, anxiety and depression. Now, new research reveals that caffeine ... pregnant. By analyzing fallopian tubes in mice, researchers found ... from the ovaries through the fallopian tubes and into the ...
... is available in French and Spanish . ... that music therapy combined with other relax techniques based on ... sleep among patients suffering from fibromyalgia. Thus, this therapy enhances ... has shown that these two techniques enhance the well-being and ...
... danger to human populations. Indeed, exposure to nuclear radiation leads ... according to a new study by Hagen Scherb and Kristina ... radiation from atomic bomb testing before the Partial Test Ban ... nuclear facilities, has had a long-term negative effect on the ...
... recently approved by the Food & Drug Administration for the treatment ... of time. A new study shows abiraterone acetate extends the ... by about four months. The study in the May 26, 2011 ... co-authored by Thomas W. Flaig, MD, medical oncologist at the University ...
Cached Medicine News:Health News:Folic acid given to mother rats protects offspring from colon cancer 2Health News:Babies May Perform 'Pure Reasoning,' Study Suggests 2Health News: Caffeine May Interfere With Fertility in Women 2Health News:Music therapy relieves fibromyalgia symptoms and improves patients' quality of life 2Health News:Nuclear radiation affects baby gender 2Health News:New drug treatment extends lives of men with prostate cancer 2
(Date:5/18/2013)... Faruqi & Faruqi, LLP, a leading ... fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or the ... ) The investigation focuses on ... securities laws by issuing materially false and/or misleading ... for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the investigation ...
(Date:5/17/2013)... May 17, 2013  Sorrento Therapeutics, Inc. (OTCBB: ... Advanced Technology Small Business Technology Transfer Research (STTR) ... and Infectious Diseases (NIAID), a division of the ... of novel human antibody therapeutics to combat ... Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... , May 17, 2013  Sony Biotechnology Inc. ("Sony") ... 8-well strip holder and 130um sorting chip.  Sony will also ... on its new SH800 Cell Sorter, the EC800 flow cytometer, ... tutorials at CYTO 2013, which will be held at the ... San Diego, California , from May 20 - ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
Inquire...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: